Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients-Reference-Cited by-同舟云学术

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Published:2016-06 Issue:6 Volume:14 Page:875-886.e6
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Berhane Sarah,Toyoda Hidenori,Tada Toshifumi,Kumada Takashi,Kagebayashi Chiaki,Satomura Shinji,Schweitzer Nora,Vogel Arndt,Manns Michael P.,Benckert Julia,Berg Thomas,Ebker Maria,Best Jan,Dechêne Alexander,Gerken Guido,Schlaak Joerg F.,Weinmann Arndt,Wörns Marcus A.,Galle Peter,Yeo Winnie,Mo Frankie,Chan Stephen L.,Reeves Helen,Cox Trevor,Johnson Philip

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers;Johnson;Cancer Epidemiol Biomarkers Prev,2014

2. Automated immunoassay system for AFP–L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis;Kagebayashi;Anal Biochem,2009

3. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

4. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

5. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis;Bolondi;Gut,2001

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision;Journal of Clinical and Experimental Hepatology;2024-11

2. Comparison of the diagnostic performance of two PIVKA-II assays using the GALAD and ASAP algorithms for detecting hepatocellular carcinoma in Chinese patients;2024-09-10

3. Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosis;eClinicalMedicine;2024-09

4. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

5. MASLD-Related Hepatocarcinoma: Special Features and Challenges;Journal of Clinical Medicine;2024-08-08